Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Shade Moody

Neurology with Special Qualifications in Child Neurology Houston, TX Medical Doctor

NPI 1285844514 CMS profile 542990

6410 Fannin St Ste 500, Ste 500, Houston, TX 77030

Open in the dashboard

General payments

$193,903

300 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$66,210 paid to institutions, not to them · program years 2023–2025

Through program year 2025, Shade Moody of Houston, TX is reported in the CMS Open Payments database as having received $193,903 across 300 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $66,210 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 98th percentile of Neurology with Special Qualifications in Child Neurology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $30,327 68
2024 General $5,992 16
2023 General $39,659 45
2022 General $42,183 47
2021 General $7,648 8
2020 General $20,736 26
2019 General $47,359 90

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Shade Moody
  • Neurology with Special Qualifications in Child Neurology median
  • Middle half of Neurology with Special Qualifications in Child Neurology
  • National median

In program year 2025, general payments to Shade Moody were reported at $30,327. Among 1,228 Neurology with Special Qualifications in Child Neurology profiles paid that year, the median was $276 and the middle half received between $87 and $1,522.

Show as a table
Year Shade Moody Neurology with Special Qualifications in Child Neurology median Middle half National median
2019 $47,359 $262 $68–$1,313 $163
2020 $20,736 $188 $46–$1,222 $114
2021 $7,648 $183 $45–$1,356 $132
2022 $42,183 $229 $72–$1,177 $149
2023 $39,659 $269 $93–$1,195 $160
2024 $5,992 $300 $98–$1,428 $164
2025 $30,327 $276 $87–$1,522 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Genentech USA, Inc. $103,269 131 payments
  2. Biogen, Inc. $69,029 120 payments
  3. AveXis $14,163 22 payments
  4. Genentech, Inc. $6,769 9 payments
  5. Genzyme Corporation $204 5 payments
  6. Abbott Laboratories $122 1 payment
  7. Janssen Scientific Affairs, LLC $121 1 payment
  8. Catalyst Pharmaceuticals, Inc. $33 1 payment
  9. Philips Electronics North America Corporation $28 2 payments
  10. NS Pharma, Inc. $27 1 payment
  11. Other $139 7 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $122,676 50 payments
  2. Travel and Lodging $28,000 122 payments
  3. Consulting Fee $26,178 13 payments
  4. Honoraria $12,290 7 payments
  5. Food and Beverage $4,552 104 payments
  6. Education $207 4 payments
Products named General payments · program years 2019–2025
  1. Evrysdi $103,313 131 payments
  2. SPINRAZA $69,006 119 payments
  3. ZOLGENSMA $14,163 22 payments
  4. Non-Covered Product $6,721 8 payments
  5. AMPLATZER $122 1 payment
  6. XARELTO $121 1 payment
  7. VILTEPSO $27 1 payment
  8. Briviact $26 1 payment
  9. Hillrom - Vest System Model 105 Home Care $23 1 payment
  10. TECFIDERA $22 1 payment
  11. Other $79 5 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

300 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Neurology with Special Qualifications in Child Neurology in Texas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record